Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.
Ellison
E C
EC
O'Dorisio
T M
TM
Benson
G D
GD
D007516:Adenoma, Islet Cell / Q000503:physiopathology*; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D005755:Gastrins / Q000378:metabolism; D006801:Humans; D007340:Insulinoma / Q000097:blood / Q000378:metabolism / Q000503:physiopathology*; D008297:Male; D015282:Octreotide; D010190:Pancreatic Neoplasms / Q000097:blood / Q000378:metabolism / Q000503:physiopathology*; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000097:blood / Q000494:pharmacology / Q000502:physiology*; D003969:Vipoma / Q000097:blood / Q000378:metabolism / Q000503:physiopathology; D015043:Zollinger-Ellison Syndrome / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*
D001786:Blood Glucose; D005755:Gastrins; D013004:Somatostatin; D015282:Octreotide